Valproate Monotherapy in the Treatment of Civilian Patients with Non-combat-related Posttraumatic Stress Disorder: An Open-Label Study [11]

Journal of Clinical Psychopharmacology

Volumn 24, Issue 1, 2004, Pages 106-108

  Otte, Christian ^a   Wiedemann, Klaus ^a   Yassouridis, Alexander ^b   Kellner, Michael ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ACCIDENT; ADULT; ASSAULT; BEHAVIOR THERAPY; CHRONIC DISEASE; CLINICAL ARTICLE; COGNITIVE THERAPY; COMORBIDITY; FEMALE; HOMICIDE; HUMAN; LETTER; LIFE EVENT; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MONOTHERAPY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; RAPE; SEXUAL ABUSE; TREATMENT OUTCOME; WITNESS;

ADMINISTRATION, ORAL; ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; STRESS DISORDERS, POST-TRAUMATIC; TIME FACTORS; TREATMENT FAILURE; URBAN POPULATION; VALPROIC ACID; VETERANS;

EID: 1642457264     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000106234.36344.a4     Document Type: Letter

References (11)

1. Charney DS, Deutch AY, Krystal JH, et al. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry. 1993;50:294-305.
2. Kellner M, Yehuda R. Do panic disorder and posttraumatic stress disorder share a common psychoneuroendocrinology? Psychoneuroendocrinology. 1999;24:485-504.
3. Post RM, Weiss N, Smith MA. Sensitization and kindling: implications for the evolving neural substrates of posttraumatic stress disorder. In: Friedmann MJ, Charney DS, Deutch AY, eds. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Philadelphia: Lippincott-Raven. 1995:203-224.
4. Davis LL, Ryan W, Adinoff B, et al. Comprehensive review of the psychiatric uses of valproate. J Clin Psychopharmacol. 2000;20(suppl 1):1-17.
5. Fesler FA. Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry. 1991;52:361-364.
6. Clark RD, Canive JM, Calais LA, et al. Divalproex in posttraumatic stress disorder: an open label clinical trial. J Trauma Stress. 1999;12:395-401.
7. Petty F, Davis LL, Nugent A, et al. Valproate therapy for chronic, combat-induced posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22:100-101.
8. Sheehan DV, Lecrubier Y, Sheehan KH. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1989;59(suppl 20):22-33.
9. Foa EB, Cashmann L, Jaycox L, et al. The validation of a self-report measure of posttraumatic stress disorder: the posttraumatic diagnostic scale. Psychol Assess. 1997;4:445-451.
10. Weiss DS, Marmar CR. The Impact of Event Scale-Revised. In: Wilson JP, Keane TM, eds. Assessing Psychological Trauma and PTSD. A Handbook for Practitioners. New York: Guilford Press; 1996:399-411.
11. Beck AT, Ward CH, Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.